THERAVECTYS Files Suit In The U.S. Against Immune Design Corporation

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--THERAVECTYS announced that it filed a lawsuit against Seattle-based Immune Design Corp. (“IDC”) in the Delaware Court of Chancery and is seeking preliminary and permanent injunctive relief, as well as monetary damages. In its suit, THERAVECTYS raises claims of tortious interference with contractual relations, misappropriation of trade secrets, unfair competition and unjust enrichment.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC